Name
EphB1+EphB2+EphB3+EphB4 Antibody, Cy5.5 Conjugated
Catalog number
bs-7045R-Cy5.5
Size
0.1ml
Price
350 EUR
Modification site
None
Gene ID number
2047
Conjugation
Cy5.5
Crossreactivity
Human
French translation
anticorps
Tested applications
IF(IHC-P)
Modification
Unmodified
Clonality
Polyclonal
Concentration
1ug per 1ul
Additional conjugation
Cy5.5,Cy5.5
Excitation Emission
675nm/694nm
Recommended dilutions
IF(IHC-P)(1:50-200)
Clone
Polyclonal antibody
Target Antigen
EphB1+EphB2+EphB3+EphB4
Category
Conjugated Primary Antibodies
Host Organism
Rabbit (Oryctolagus cuniculus)
Purification method
This antibody was purified via Protein A.
Long name
EphB1+EphB2+EphB3+EphB4 Antibody, Cy5.5 Conjugated
Specificity
This is a highly specific antibody against EphB1+EphB2+EphB3+EphB4.
Source
KLH conjugated synthetic peptide derived from human EphB1+EphB2+EphB3+EphB4
Conjugated
These antibodies are excite for emission at 678nm and detected at a 694 nm wavelengths.
Crossreactive species details
Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.
Storage conditions
Keep the antibody in an aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store refrigerated at 2 to 8 degrees Celcius for up to 1 year.
Properties
If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.Cy5 antibodies are excited by the 650-nanometer wave of an argon laser and detected at a 670-nanometer captor.
Antigen background
Receptor for members of the ephrin-B family. Binds to ephrin-B1, -B2 and -B3. Binding with the guidance cue ephrin-B2 at the optic chiasm midline redirect ventrotemporal (VT) retinal ganglion cells (RGCs) axons ipsilaterally. May be involved in cell-cell interactions in the nervous system.
Synonyms
CAPB;DRT;EK2;EK5;EK6;ELK;elk related tyrosine kinase;EPH like kinase 2;EPH like kinase 6;EPH like tyrosine kinase 2;eph tyrosine kinase 2;eph tyrosine kinase 3;EPH-like kinase 6;Ephb1;EPHB1_HUMAN;EPHB2;EPHB3;EPHB4;ephrin receptor EphB4;ephrin type B receptor 1;ephrin type B receptor 2;ephrin type B receptor 3;ephrin type B receptor 4;Ephrin type-B receptor 1;EPHT2;EPHT3;ERK;ETK2;Hek 5;Hek 6;HEK2;HEK5;HEK6;hepatoma transmembrane kinase;HTK;human embryo kinase 2;MYK1;NET;PCBC;protein tyrosine kinase HEK5;renal carcinoma antigen NY REN 47;soluble EPHB1 variant 1;soluble EPHB4 variant 1;soluble EPHB4 variant 2;soluble EPHB4 variant 3;TYRO11;Tyro5;TYRO6;tyrosine protein kinase receptor EPH 2;tyrosine protein kinase receptor EPH 3;tyrosine protein kinase receptor EPH2;tyrosine protein kinase receptor EPH3;tyrosine protein kinase receptor HTK;tyrosine protein kinase TYRO11;tyrosine protein kinase TYRO5;tyrosine protein kinase TYRO6;Tyrosine-protein kinase receptor EPH-2.